HSBC Holdings’s Elanco Animal Health ELAN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$972K Buy
40,631
+19,502
+92% +$477K ﹤0.01% 1876
2025
Q4
$478K Sell
21,129
-2,048
-9% -$44.6K ﹤0.01% 2342
2025
Q3
$467K Sell
23,177
-103,157
-82% -$1.73M ﹤0.01% 2143
2025
Q2
$1.8M Buy
126,334
+102,686
+434% +$1.2M ﹤0.01% 1530
2025
Q1
$248K Sell
23,648
-87,750
-79% -$993K ﹤0.01% 2494
2024
Q4
$1.34M Sell
111,398
-437,886
-80% -$5.73M ﹤0.01% 1654
2024
Q3
$8.14M Buy
549,284
+531,189
+2,936% +$7.4M ﹤0.01% 966
2024
Q2
$261K Sell
18,095
-698,718
-97% -$11.2M ﹤0.01% 2383
2024
Q1
$11.7M Buy
716,813
+507,836
+243% +$7.94M 0.01% 829
2023
Q4
$3.13M Buy
208,977
+176,656
+547% +$2M ﹤0.01% 1316
2023
Q3
$364K Sell
32,321
-999,139
-97% -$11.6M ﹤0.01% 2109
2023
Q2
$10.4M Sell
1,031,460
-188,392
-15% -$1.75M 0.01% 803
2023
Q1
$11.5M Sell
1,219,852
-1,062,630
-47% -$12.5M 0.01% 794
2022
Q4
$27.6M Buy
2,282,482
+761,814
+50% +$9.5M 0.03% 540
2022
Q3
$19.3M Sell
1,520,668
-809,957
-35% -$14.2M 0.03% 559
2022
Q2
$45.7M Sell
2,330,625
-50,557
-2% -$1.2M 0.06% 311
2022
Q1
$63.6M Buy
2,381,182
+695,118
+41% +$18.5M 0.08% 249
2021
Q4
$47.9M Sell
1,686,064
-528,598
-24% -$16.4M 0.04% 400
2021
Q3
$70.6M Buy
2,214,662
+599,143
+37% +$20.1M 0.07% 244
2021
Q2
$56.2M Buy
1,615,519
+925,539
+134% +$30.5M 0.06% 313
2021
Q1
$20.3M Buy
689,980
+458,632
+198% +$14.1M 0.02% 586
2020
Q4
$7.07M Buy
231,348
+161,567
+232% +$4.93M 0.01% 893
2020
Q3
$1.93M Sell
69,781
-5,183
-7% -$131K ﹤0.01% 1289
2020
Q2
$1.61M Buy
74,964
+8,831
+13% +$195K ﹤0.01% 1248
2020
Q1
$1.49M Sell
66,133
-5,201
-7% -$142K ﹤0.01% 1305
2019
Q4
$2.07M Buy
71,334
+21,883
+44% +$595K ﹤0.01% 1486
2019
Q3
$1.31M Sell
49,451
-266,351
-84% -$7.99M ﹤0.01% 1813
2019
Q2
$10.7M Buy
315,802
+274,941
+673% +$8.93M 0.02% 801
2019
Q1
$1.31M Buy
+40,861
New +$1.26M ﹤0.01% 1693

Other funds holding ELAN

HSBC Holdings's ELAN Position: Q1 2026 in Review

HSBC Holdings increased its Elanco Animal Health (ELAN) stake by 92% in Q1 2026, buying an estimated $477K and bringing the position to 40,631 shares worth $972K. The position accounts for ﹤0.01% of the portfolio, ranked #1876.

HSBC Holdings first reported a position in ELAN in Q1 2019 and has held it in 29 quarters since. The position peaked at $70.6M in Q3 2021. 516 funds tracked by Wall St. Rank hold ELAN as of Q1 2026.

  • HSBC Holdings held 40,631 shares of Elanco Animal Health worth $972K as of Q1 2026.
  • HSBC Holdings bought 19,502 Elanco Animal Health shares in Q1 2026, an estimated $477K.
  • Elanco Animal Health made up ﹤0.01% of HSBC Holdings's portfolio in Q1 2026, its #1876 holding.
  • HSBC Holdings first reported a position in Elanco Animal Health in Q1 2019 and has held it in 29 quarters since.
  • HSBC Holdings's Elanco Animal Health position peaked at $70.6M in Q3 2021.
  • 516 funds tracked by Wall St. Rank held Elanco Animal Health as of Q1 2026.

Based on HSBC Holdings's 13F filing for Q1 2026, filed 30 Apr 2026.